Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|January 1, 2020
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in miceFrancesca Ferlenghi, Riccardo Castelli, Laura Scalvini, et al.Shock (Augusta, Ga.)|May 5, 2017
Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion InjuryValentina Vivo, Irene Zini, Anna Maria Cantoni, et al.Journal of Medicinal Chemistry|May 4, 2016
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung TumorsRiccardo Castelli, Arianna Giacomini, Mattia Anselmi, et al.Glycobiology|August 18, 2009
Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from Mycobacterium tuberculosisTracy K Carlson, Jordi B Torrelles, Kelly Smith, et al.Pharmaceuticals (Basel, Switzerland)|April 23, 2020
Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC min/J MiceMiriam Corrado, Carmine Giorgio, Elisabetta Barocelli, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B SignalingCarmine Giorgio, Marika Allodi, Simone Palese, et al.Cancer Gene Therapy|August 24, 2021
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrinMarco Rusnati, Giulia Paiardi, Chiara Tobia, et al.Chemistry, an Asian Journal|June 26, 2014
Activation of glycosyl halides by halogen bondingRiccardo Castelli, Severin Schindler, Sebastian M Walter, et al.Plos One|June 9, 2015
Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in RatsFederica Vacondio, Michele Bassi, Claudia Silva, et al.Journal of Molecular Biology|April 17, 2007
The novel fold of scytovirin reveals a new twist for antiviral entry inhibitorsRobert L McFeeters, Changyun Xiong, Barry R O'Keefe, et al.Pageof 6